Search Results - Gómez-España, M.A

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    1839 Association of advanced breast cancer HER-2 positive treated with trastuzumab and Killer cell immunoglobulin-like receptors (KIRs) polymorphisms according to estrogen and progesterone receptor status

    1839 Association of advanced breast cancer HER-2 positive treated with trastuzumab and Killer cell immunoglobulin-like receptors (KIRs) polymorphisms according to estrogen and prog... by Morales-Estevez, C, López-González, J, Manzanares-Martín, B, González-Fernández, R, Ortiz-Morales, M.J, Porras-Quintela, I, Gómez-España, M.A, Moreno-Vega, A, Cano-Osuna, M, Serrano-Blanch, R, De la Haba-Rodríguez, J, Aranda-Aguilar, E

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

    A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients by Toledano-Fonseca, M., Gómez-España, M.A., Élez, E., Grávalos, C., García-Alfonso, P., Rodríguez, R., Losa, F., Alés Díaz, I., Graña, B., Valladares-Ayerbes, M., García-Ortiz, M.V., Polo, E., Salgado, M., Rivera, F., Safont, M.J., Salud, A., Ruiz-Casado, A., Tabernero, J.M., Riesco, M.C., Rodríguez-Ariza, A., Aranda, E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

    Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of t... by Jiménez-Fonseca, P., Sastre, J., García-Alfonso, P., Gómez-España, M.A., Salud, A., Gil, S., Rivera, F., Reina, J.J., Quintero, G., Valladares-Ayerbes, M., Safont, M.J., La Casta, A., Robles-Díaz, L., García-Paredes, B., López López, R., Guillot, M., Gallego, J., Alonso-Orduña, V., Diaz-Rubio, E., Aranda, E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial

    Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic... by García-Alfonso, P., Elez, E., Soto-Alsar, J., Páez, D., Fernández-Montes, A., Graña, B., Salud, A., Yubero, A., Gómez-España, M.A., Macías, I., Quintero, G., López-López, C., Fernández-Rodríguez, T., Grávalos, C., González-Flores, E., Guix, M., García Paredes, B., Reina, J.J., Rodríguez Mowbray, J.R., Sastre, J., Aranda, E.

    Published in ESMO open
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    53P Oral metronomic-continuous cyclophosphamide (MCy) for elderly or unfit patients with advanced soft tissue sarcoma (STS): Reina Sofía University Hospital experience

    53P Oral metronomic-continuous cyclophosphamide (MCy) for elderly or unfit patients with advanced soft tissue sarcoma (STS): Reina Sofía University Hospital experience by Moreno Vega, A.L., Navarro Berlanga, L., Plaza Borrego, R., Caro Cuenca, M.T., Gomez España, M.A., Aranda Aguilar, E.

    Published in ESMO open
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: